Alert detail

FDA Approval: EPIDIOLEX (CANNABIDIOL) — Type 1 - New Molecular Entity

Policy ID: FDA-NDA210365Specialty: NeurologyAdded: 6/10/2026Effective: 2018-06-25federal register
Routine

Full alert analysis requires a subscription

Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.